Disruptive Dose Josh Simon

SVP, Social Center of Excellence, Centered CMI Media Group

March 2025

In this DHCG Disruptive Dose, Mark Bard of the DHC Group sits down with Josh Simon, SVP of the Social Center of Excellence at CMI Media Group, to discuss the evolving landscape of social influencers in pharma. They explore the shift from celebrity-driven content to authentic partnerships with HCPs and patients, the challenges of balancing compliance with genuine storytelling, and the differences between consumer, patient, and physician influencers. Josh shares insights on sourcing true digital opinion leaders, the growing role of micro-influencers, and how smaller pharma companies leverage them as a competitive advantage.